Effectiveness of intraportal mexidol infusions in the treatment of obstructive jaundice.
Beliaev
A N
AN
Mokshina
E I
EI
Beliaev
S A
SA
Mel'nikova
D V
DV
Kostin
S V
SV
Khvostunova
S I
SI
Bukharkin
M N
MN
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D001219:Aspartate Aminotransferases / Q000097:blood; D004195:Disease Models, Animal; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D007262:Infusions, Intravenous; D041781:Jaundice, Obstructive / Q000097:blood / Q000188:drug therapy*; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D008163:Luminescent Measurements; D010847:Picolines / Q000008:administration & dosage*; D011169:Portal Vein; D016896:Treatment Outcome
D000975:Antioxidants; D010847:Picolines; C070020:emoxypine succinate; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase